139 related articles for article (PubMed ID: 32014279)
1. Early Hyperbilirubinemia in Neonates with Down Syndrome.
Bahr TM; Henry E; Hulse W; Baer VL; Prchal JT; Bhutani VK; Christensen RD
J Pediatr; 2020 Apr; 219():140-145. PubMed ID: 32014279
[TBL] [Abstract][Full Text] [Related]
2. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use.
Kuzniewicz MW; Escobar GJ; Newman TB
Pediatrics; 2009 Oct; 124(4):1031-9. PubMed ID: 19786442
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors and Predictors of Rebound Hyperbilirubinemia in a Term and Late-Preterm Infant with Hemolysis.
Almohammadi H; Nasef N; Al-Harbi A; Saidy K; Nour I
Am J Perinatol; 2022 Jun; 39(8):836-843. PubMed ID: 33231268
[TBL] [Abstract][Full Text] [Related]
4. Systematic follow-up of hyperbilirubinemia in neonates with a gestational age of 35 to 37 weeks.
Punaro E; Mezzacappa MA; Facchini FP
J Pediatr (Rio J); 2011; 87(4):301-6. PubMed ID: 21655685
[TBL] [Abstract][Full Text] [Related]
5. Changes in total serum bilirubin during phototherapy in late preterm and term infants with non-haemolytic hyperbilirubinemia.
Dani C; Becciani S; Pratesi S
Early Hum Dev; 2019 Apr; 131():41-44. PubMed ID: 30831388
[TBL] [Abstract][Full Text] [Related]
6. Association Between Laboratory Calibration of a Serum Bilirubin Assay, Neonatal Bilirubin Levels, and Phototherapy Use.
Kuzniewicz MW; Greene DN; Walsh EM; McCulloch CE; Newman TB
JAMA Pediatr; 2016 Jun; 170(6):557-61. PubMed ID: 27064480
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study.
Xu C; Bao Y; He Y; Wu M; Zhu J
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760
[TBL] [Abstract][Full Text] [Related]
8. Genetic Factors and Delayed TSB Monitoring and Treatment as Risk Factors Associated with Severe Hyperbilirubinemia in Term Neonates Admitted for Phototherapy.
Boo NY; Sin S; Chee SC; Mohamed M; Ahluwalia AK; Ling MM; Ong HK
J Trop Pediatr; 2020 Dec; 66(6):569-582. PubMed ID: 32577754
[TBL] [Abstract][Full Text] [Related]
9. Bilirubin nomogram for prediction of significant hyperbilirubinemia in north Indian neonates.
Pathak U; Chawla D; Kaur S; Jain S
Indian Pediatr; 2013 Apr; 50(4):383-9. PubMed ID: 23255694
[TBL] [Abstract][Full Text] [Related]
10. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.
Bhutani VK; Stark AR; Lazzeroni LC; Poland R; Gourley GR; Kazmierczak S; Meloy L; Burgos AE; Hall JY; Stevenson DK;
J Pediatr; 2013 Mar; 162(3):477-482.e1. PubMed ID: 23043681
[TBL] [Abstract][Full Text] [Related]
11. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.
Bhutani VK; Johnson L; Sivieri EM
Pediatrics; 1999 Jan; 103(1):6-14. PubMed ID: 9917432
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: a nested case-control study.
Kuzniewicz MW; Escobar GJ; Wi S; Liljestrand P; McCulloch C; Newman TB
J Pediatr; 2008 Aug; 153(2):234-40. PubMed ID: 18534217
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral agar in management of indirect hyperbilirubinemia in full-term neonates.
Abdel-Aziz Ali SM; Mansour Galal S; Sror SM; Hussein O; Abd-El-Haseeb Ahmed AO; Hamed EA
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):975-980. PubMed ID: 32192396
[TBL] [Abstract][Full Text] [Related]
14. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program.
Christensen RD; Baer VL; MacQueen BC; O'Brien EA; Ilstrup SJ
J Perinatol; 2018 May; 38(5):517-525. PubMed ID: 29410540
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of cord blood bilirubin for hyperbilirubinemia in neonates at risk for maternal-fetal blood group incompatibility and hemolytic disease of the newborn.
Calkins K; Roy D; Molchan L; Bradley L; Grogan T; Elashoff D; Walker V
J Neonatal Perinatal Med; 2015; 8(3):243-50. PubMed ID: 26518407
[TBL] [Abstract][Full Text] [Related]
16. Hour-Specific Total Serum Bilirubin Percentiles for Infants Born at 29-35 Weeks' Gestation.
Jegathesan T; Ray JG; Bhutani VK; Keown-Stoneman CDG; Campbell DM; Shah V; Berger H; Hayeems RZ; Sgro M;
Neonatology; 2021; 118(6):710-719. PubMed ID: 34710869
[TBL] [Abstract][Full Text] [Related]
17. Discharge of newborns with risk factors of severe hyperbilirubinemia: description of a hospital at home-based care monitoring and phototherapy.
Coquery SS; Georges A; Cortey A; Floch C; Avran D; Gatbois E; Mehler-Jacob C; de Stampa M
Eur J Pediatr; 2022 Aug; 181(8):3075-3084. PubMed ID: 35695955
[TBL] [Abstract][Full Text] [Related]
18. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system.
Eggert LD; Wiedmeier SE; Wilson J; Christensen RD
Pediatrics; 2006 May; 117(5):e855-62. PubMed ID: 16651290
[TBL] [Abstract][Full Text] [Related]
19. Pre-phototherapy total serum bilirubin levels in extremely preterm infants.
Jegathesan T; Ray JG; Keown-Stoneman CDG; Campbell DM; Shah V; Berger H; Hayeems RZ; Sgro M;
Pediatr Res; 2023 Jan; 93(1):226-232. PubMed ID: 35523883
[TBL] [Abstract][Full Text] [Related]
20. Umbilical cord blood bilirubins, gestational age, and maternal race predict neonatal hyperbilirubinemia.
Castillo A; Grogan TR; Wegrzyn GH; Ly KV; Walker VP; Calkins KL
PLoS One; 2018; 13(6):e0197888. PubMed ID: 29856776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
